🇬🇧 Facilitate the development of therapies to prevent and cure Type 1 diabetes through a network of excellence

Abstract

Manuela Battaglia is an immunologist by training and she became a scientist to transform patients’ lives. She spent 20 productive years in academic research mainly focused on understanding the pathogenesis of type 1 diabetes (T1D).

When she was Vice-Director of the San Raffaele Diabetes Research Institute in Milano (Italy), she decided to enter into a different path to reach a higher impact on patients and society. She then spent the following 4 years in leading managerial positions in international organizations focused on reducing the waste of talent, research, and funds in the biomedical field for the benefit of patients.

She is now capitalizing on her scientific and managerial competencies in the
International non-profit organization (iVZW) INNODIA: an innovative initiative that, stemming from an extremely successful European-funded project, efficiently and wisely matchmakes those who want to develop new cures and promote disease-modifying therapies for type 1 diabetes and those who have the knowledge, tools, experience, resources, and the urgent craving to do so.

In this lecture, she will describe the model on which the INNODIA organization is based, she will provide an updated overview of the INNODIA Network, and will present the next steps and challenges the field of type 1 diabetes is facing and how INNODIA is getting ready to face them.